MANNELLI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 18.078
EU - Europa 9.702
AS - Asia 6.952
SA - Sud America 1.039
AF - Africa 200
OC - Oceania 147
Continente sconosciuto - Info sul continente non disponibili 4
Totale 36.122
Nazione #
US - Stati Uniti d'America 17.902
RU - Federazione Russa 3.428
SG - Singapore 1.907
PL - Polonia 1.644
CN - Cina 1.501
HK - Hong Kong 1.224
IT - Italia 878
SE - Svezia 876
IE - Irlanda 862
VN - Vietnam 851
BR - Brasile 820
KR - Corea 617
DE - Germania 457
UA - Ucraina 394
FI - Finlandia 319
FR - Francia 315
IN - India 253
GB - Regno Unito 216
AU - Australia 141
JO - Giordania 115
CA - Canada 100
AR - Argentina 96
BD - Bangladesh 91
CH - Svizzera 89
ID - Indonesia 66
NL - Olanda 66
TR - Turchia 62
JP - Giappone 61
IQ - Iraq 46
EC - Ecuador 41
ES - Italia 38
MX - Messico 37
CI - Costa d'Avorio 34
BE - Belgio 33
NG - Nigeria 33
ZA - Sudafrica 33
AT - Austria 22
CO - Colombia 22
MA - Marocco 19
PK - Pakistan 19
VE - Venezuela 18
PY - Paraguay 17
SC - Seychelles 15
EG - Egitto 13
PH - Filippine 13
CZ - Repubblica Ceca 12
DZ - Algeria 12
MY - Malesia 12
NP - Nepal 12
SA - Arabia Saudita 12
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
CL - Cile 11
CR - Costa Rica 11
TN - Tunisia 10
LT - Lituania 9
AL - Albania 7
AZ - Azerbaigian 7
JM - Giamaica 7
KE - Kenya 7
KG - Kirghizistan 7
UY - Uruguay 7
IL - Israele 6
NZ - Nuova Zelanda 6
PE - Perù 6
PS - Palestinian Territory 6
AM - Armenia 5
BG - Bulgaria 5
BJ - Benin 5
DO - Repubblica Dominicana 5
GE - Georgia 5
HU - Ungheria 5
BY - Bielorussia 4
KZ - Kazakistan 4
OM - Oman 4
RO - Romania 4
SN - Senegal 4
TH - Thailandia 4
AO - Angola 3
EU - Europa 3
GR - Grecia 3
HN - Honduras 3
MD - Moldavia 3
MU - Mauritius 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
BH - Bahrain 2
BN - Brunei Darussalam 2
BZ - Belize 2
ET - Etiopia 2
GA - Gabon 2
GD - Grenada 2
KW - Kuwait 2
MK - Macedonia 2
NI - Nicaragua 2
PT - Portogallo 2
RS - Serbia 2
TW - Taiwan 2
BB - Barbados 1
BO - Bolivia 1
Totale 36.098
Città #
Santa Clara 2.555
Fairfield 1.963
Ashburn 1.879
Warsaw 1.638
Singapore 1.380
Hong Kong 1.016
Woodbridge 936
Chandler 863
Dublin 861
Seattle 793
Cambridge 781
Dallas 711
Houston 703
Jacksonville 638
Wilmington 624
Seoul 612
San Jose 501
Ann Arbor 362
Beijing 352
Princeton 260
Lawrence 254
Ho Chi Minh City 251
Hefei 243
Altamura 230
Buffalo 219
Los Angeles 218
Lauterbourg 204
The Dalles 198
Hanoi 187
Moscow 165
Boston 164
Florence 161
Mumbai 157
Boardman 156
Council Bluffs 137
Melbourne 136
Medford 122
Munich 112
New York 106
San Diego 99
Bern 84
Shanghai 84
Helsinki 64
West Jordan 62
Dong Ket 59
Milan 57
Paris 54
São Paulo 53
Tokyo 53
Turku 51
Clifton 46
Kent 46
Redondo Beach 46
Jakarta 45
Norwalk 42
Amsterdam 41
Haiphong 40
Toronto 37
Falls Church 36
Izmir 35
Abidjan 34
Brussels 32
Da Nang 32
Chicago 31
Orem 31
Hillsboro 30
London 30
Abuja 29
Brooklyn 27
Frankfurt am Main 27
Phoenix 26
Rio de Janeiro 25
Bologna 24
Guangzhou 23
Andover 22
Montreal 22
Voghera 22
Yubileyny 22
Chennai 20
Johannesburg 20
Baghdad 19
Pune 19
Belo Horizonte 18
Hải Dương 18
Prato 18
Vienna 18
Barcelona 16
Campinas 16
Atlanta 15
Biên Hòa 15
Bremen 15
Buenos Aires 15
Guayaquil 15
Denver 14
Zola Predosa 14
Can Tho 13
Porto Alegre 13
Rome 13
Tianjin 13
San Francisco 12
Totale 24.820
Nome #
(0) Save to: more options SPECT semiquantitative analysis of adrenocortical. I-131-6 beta-iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma 1.327
2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma 358
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling. 351
Incidental and metastatic adrenal masses 326
Seladin-1 expression is regulated by promoter methylation inadrenal cancer 309
Metformin as a new anti-cancer drug in adrenocortical carcinoma 308
NEW INSIGHTS IN THE CLINICAL AND TRANSLATIONAL RELEVANCE OF miR483-5p IN ADRENOCORTICAL CANCER 302
Feasibility and safety of minimal-incision thyroidectomy for Graves' disease: A prospective, single-center study 293
DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: Beyond pheochromocytomas and paragangliomas 291
Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma. 284
Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors. 276
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. 272
A case of malignant insulinoma responsive to somatostatin analogs treatment 241
Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model. 224
Genetic-clinical profile of subjects with apparently sporadic extra-adrenal paragangliomas. 223
A unique neuroendocrine cell model derived from the human foetal neural crest. 223
Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma 221
Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis. 219
The Adipose Stem Cell as a Novel Metabolic Actor in Adrenocortical Carcinoma Progression: Evidence from an In Vitro Tumor Microenvironment Crosstalk Model 218
Epigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas. 218
DETECTION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH ADRENOCORTICAL CARCINOMA: A MONOCENTRIC PRELIMINARY STUDY. 208
Expression of the novel adrenocorticotropin-responsive gene selective Alzheimer's disease indicator-1 in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. 202
15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma 202
Fascin-1 is a Novel Prognostic Biomarker Associated with Tumor Invasiveness in Adrenocortical Carcinoma. 202
A case of hyponatremia caused by central hypocortisolism 201
DISSECTING THE ORIGIN OF INDUCIBLE BROWN FAT IN ADULT HUMANS THROUGH A NOVEL ADIPOSE STEM CELL MODEL FROM ADIPOSE TISSUE SURROUNDING PHEOCHROMOCYTOMA 198
The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells. 195
Rare diseases in clinical endocrinology: a taxonomic classification system. 190
A nonsecreting pheochromocytoma presenting as an incidental adrenal mass. Report on a case. 188
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients 188
Adrenal incidentaloma: the influence of a decision-making algorithm on the short-term outcome of laparoscopy 187
Clinical impact of the new SIAPEC-IAP classification on the indeterminate category of thyroid nodules 187
The role of PPAR-γ system in normal and tumoral corticotroph pituitary and adrenal cells. 186
Il dosaggio delle metanefrine nella diagnosi del feocromocitoma: vantaggi clinici e problematiche di laboratorio 186
Analysis of circulating microRNAs in adrenocortical tumors. 186
Metformin Treatment Induces Different Response in Pheochromocytoma/Paraganglioma Tumour Cells and in Primary Fibroblasts 185
Quantitative value of aldosterone-renin ratio for detection of aldosterone-producing adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) study 185
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy 184
Genetic screening for pheochromocytoma: should SDHC gene analysis be included? 184
Effects of prostaglandin E2 inhibition on norepinephrine plasma levels after adrenergic stimulation in man. 184
Cushing's syndrome due to intermittent ectopic ACTH production showing a temporary remission during a pulmonary infection 180
Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release. 180
A study on human adrenal secretion. Measurement of epinephrine, norepinephrine, dopamine and cortisol in peripheral and adrenal venous blood under surgical stress. 179
Morphofunctional effects of mitotane on mitochondria in human adrenocortical cancer cells. 179
Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations 178
A further case of giant intrasellar carotid aneurysm mimicking a pituitary adenoma: the relevance of a multivariate approach in differential diagnosis. 178
The role of metabolic changes in shaping the fate of cancer-associated adipose stem cells 177
Adrenal medulla secretion in Cushing's syndrome. 177
Effects of thyroid replacement therapy on catecholamine plasma levels. 176
SDH mutations in patients affected by paraganglioma syndromes: a personal experience. 176
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy 175
Sunitinib in the therapy of malignant paragangliomas: Report on the efficacy in a sdhb mutation carrier and review of the literature 175
Phenotype variability of neural crest-derived tumours in six Italian families segregating the same founder SDHD mutation Q109X. 174
Acute effect of furosemide on renal kallikrein and prostaglandin systems in mild to moderate essential hypertension. 174
Localization of endothelin-converting enzyme-1 in human kidney 172
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma. 170
Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study 169
Adjuvant mitotane treatment for adrenocortical carcinoma 168
The microenvironment induces collective migration in SDHB-silenced mouse pheochromocytoma spheroids 167
Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how? 167
Caratterizzazione genomica del carcinoma surrenalico 167
SDHx and Non-Chromaffin Tumors: A Mediastinal Germ Cell Tumor Occurring in a Young Man with Germline SDHB Mutation 167
Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride: an in vivo and in vitro study. 166
Measurement of catecholamines, met-enkephalin, somatostatin and substance P-like immunoreactivities in 12 human pheochromocytomas. 166
Mitochondrial function and content in Pheochromocytoma/paraganglioma of succinate dehydrogenase mutation carriers 166
Carbonic anhydrases III and IX are new players in the crosstalk between adrenocortical carcinoma and its altered adipose microenvironment 165
Yeast model for evaluating the pathogenic significance of SDHB, SDHC and SDHD mutations in PHEO-PGL syndrome. 165
Novel Somatic Mutations in the Catalytic Subunit of the Protein Kinase A as a Cause of Adrenal Cushing's Syndrome: A European Multicentric Study. 165
Human fetal adrenal cells retain age-related stem- and endocrine-differentiation potential in culture 165
Presence and distribution of endothelin-1 gene expression in human kidney. 164
MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma 164
A prospective study of the prevelence of primary aldosteronism in 1,125 hypertensive patients 161
Handgrip-induced airway dilation in asthmatic patients with bronchoconstriction induced by MCh inhalation. 161
Role of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function 161
Pheochromocytoma in Italy: a multicentric retrospective study. 160
[Diagnostic problems in pheochromocytoma] 160
Integrated genomic characterization of adrenocortical carcinoma. 159
Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma 159
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma 158
The 3D in vitro Adrenoid cell model recapitulates the complexity of the adrenal gland 158
[Peripheral dopamine DA1-type receptors: their localization, functional role and possible clinical implications] 158
Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation 158
DNA methylation is an independent prognostic marker of survival in adrenocortical cancer 157
Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. 157
Altered renal and platelet arachidonic acid metabolism in cirrhosis. 156
Functional significance of germline EPAS1 variants 156
False serum calcitonin high levels using a non-competitive two-site IRMA. 155
Ipertensione ed esercizio fisico 155
Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling. 155
Krebs Cycle Metabolite Profiling for Identification and Stratification of Pheochromocytomas/Paragangliomas due to Succinate Dehydrogenase Deficiency. 155
Clinical aspects of SDHx-related pheochromocytoma and paraganglioma. 154
Clinical relevance of phenotype/genotype correlations in the diagnosis and therapy of pheochromocytomas/paragangliomas. 154
Prognostic and monitoring value of circulating tumour cells in adrenocortical carcinoma: a preliminary monocentric study. 154
Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma 154
Functional study in a yeast model of a novel succinate-dehydrogenase subunit B gene germline missense mutation (C191Y) diagnosed in a patient affected by a glomus tumor. 153
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. 152
Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and/or functional or non-functional paragangliomas. 152
The Y606C RET mutation causes a receptor gain of function. 151
In vivo evidence that endogenous dopamine modulates sympathetic activity in man. 151
Variable expression of the transcription factors cAMP response element-binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. 151
Totale 20.148
Categoria #
all - tutte 97.385
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.385


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021402 0 0 0 0 0 0 0 0 0 0 154 248
2021/20221.583 49 134 119 69 72 94 54 120 95 93 256 428
2022/20233.928 418 695 179 278 317 718 497 184 380 29 121 112
2023/20241.381 65 156 252 79 98 166 35 241 27 122 92 48
2024/20258.711 344 1.043 596 1.480 2.342 865 151 624 419 221 312 314
2025/202610.031 1.126 1.713 1.260 939 1.114 414 1.291 581 690 651 252 0
Totale 36.361